Company Profile
InVivo Therapeutics Stock Price, News & Analysis
- Ticker:
- NVIV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for NVIV.
Company overview
Business overview
InVivo Therapeutics is a medical technology company focused on spinal cord injury and neurotrauma-related devices or therapies. Its business has centered on nervous-system repair rather than classic therapeutics.
Geographic Base and Sector Classification
InVivo Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
Business Model Characteristics
The company depends on product or therapy development, clinical progress, and the ability to maintain a viable path in a difficult indication. Investors usually watch regulatory updates, commercialization strategy, and capital runway.
Position Within the Biotechnology Landscape
InVivo occupies a niche neurorepair position within healthcare innovation. It is not a typical biotech drug stock, but it remains tied to a high-unmet-need clinical area.
Future catalysts
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone. The market is mainly focused on residual value.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does InVivo Therapeutics do?
InVivo Therapeutics is a medical technology company focused on spinal cord injury and neurotrauma-related devices or therapies. Its business has centered on nervous-system repair rather than classic therapeutics.
On which exchange is NVIV stock listed?
InVivo Therapeutics (NVIV) is associated with NASDAQ, United States, Biopharma.
What is InVivo?
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone.
Which conditions is InVivo Therapeutics targeting with InVivo?
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone.
How does InVivo Therapeutics describe recent progress with InVivo?
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone.
What is Therapeutics?
InVivo Therapeutics is a medical technology company focused on spinal cord injury and neurotrauma-related devices or therapies.
What should investors watch for with Therapeutics?
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone.
What future catalysts are investors watching for InVivo Therapeutics?
InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone. The market is mainly focused on residual value.